Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRSEVIMAB for Antiviral prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 27 adverse event reports in the FDA FAERS database where NIRSEVIMAB was used for Antiviral prophylaxis.

Most Reported Side Effects for NIRSEVIMAB

Side Effect Reports % Deaths Hosp.
Respiratory syncytial virus bronchiolitis 87 35.2% 0 57
Drug ineffective 65 26.3% 0 53
Respiratory syncytial virus infection 38 15.4% 0 38
Cough 19 7.7% 0 16
Pyrexia 15 6.1% 0 10
Apnoea 14 5.7% 0 6
Bronchiolitis 14 5.7% 1 11
Wheezing 13 5.3% 0 7
Incorrect dose administered 12 4.9% 0 3
Syringe issue 11 4.5% 0 0
Enteral nutrition 9 3.6% 0 9
Bradycardia 8 3.2% 1 6
Hypoxia 7 2.8% 0 7
Respiratory syncytial virus test positive 7 2.8% 0 4
Rhinitis 7 2.8% 0 7

Other Indications for NIRSEVIMAB

Respiratory syncytial virus immunisation (56) Immunisation (24) Prophylaxis (9) Product used for unknown indication (7) Respiratory syncytial virus bronchiolitis (7)

Other Drugs Used for Antiviral prophylaxis

PALIVIZUMAB (3,080) VALGANCICLOVIR (1,515) VALACYCLOVIR (1,050) ACYCLOVIR (749) LETERMOVIR (574) GANCICLOVIR (463) OSELTAMIVIR (444) LAMIVUDINE (299) NIRSEVIMAB-ALIP (137) SULFAMETHOXAZOLE\TRIMETHOPRIM (123)

Related Pages

NIRSEVIMAB Full Profile All Antiviral prophylaxis Drugs NIRSEVIMAB Demographics NIRSEVIMAB Timeline